Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EW

Edwards Lifesciences Corp

Oct 31 • 04:00PM ET

82.45

-1.03 -1.23 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO VO IVV SPY VTV VOT XLV IHI RSP

Scroll to Statements

Index	S&P 500	P/E	35.15	EPS (ttm)	2.35	Insider Own	2.05%	Shs Outstand	587.10M	Perf Week	8.34%
Market Cap	48.41B	Forward P/E	28.89	EPS next Y	2.85	Insider Trans	-0.52%	Shs Float	575.05M	Perf Month	7.57%
Enterprise Value	46.07B	PEG	3.65	EPS next Q	0.62	Inst Own	87.37%	Short Float	1.35%	Perf Quarter	2.95%
Income	1.38B	P/S	8.23	EPS this Y	5.66%	Inst Trans	-2.91%	Short Ratio	1.76	Perf Half Y	8.99%
Sales	5.88B	P/B	4.60	EPS next Y	11.14%	ROA	11.98%	Short Interest	7.79M	Perf YTD	11.37%
Book/sh	17.94	P/C	16.14	EPS next 5Y	9.64%	ROE	15.71%	52W High	84.66 -2.61%	Perf Year	18.86%
Cash/sh	5.11	P/FCF	82.34	EPS past 3/5Y	-15.06% -2.36%	ROIC	12.29%	52W Low	64.89 27.06%	Perf 3Y	-4.97%
Dividend Est.	-	EV/EBITDA	27.13	Sales past 3/5Y	1.30% 4.58%	Gross Margin	79.79%	Volatility	5.26% 2.78%	Perf 5Y	5.60%
Dividend TTM	-	EV/Sales	7.83	EPS Y/Y TTM	-39.83%	Oper. Margin	27.09%	ATR (14)	2.38	Perf 10Y	230.06%
Dividend Ex-Date	-	Quick Ratio	3.87	Sales Y/Y TTM	0.19%	Profit Margin	23.43%	RSI (14)	68.60	Recom	1.94
Dividend Gr. 3/5Y	- -	Current Ratio	4.68	EPS Q/Q	229.49%	SMA20	7.28%	Beta	1.03	Target Price	93.81
Payout	0.00%	Debt/Eq	0.06	Sales Q/Q	14.67%	SMA50	6.30%	Rel Volume	2.61	Prev Close	83.48
Employees	15800	LT Debt/Eq	0.06	Earnings	Oct 30 AMC	SMA200	9.70%	Avg Volume	4.42M	Price	82.45
IPO	Mar 27, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.40% 3.69%	Trades		Volume	11,511,706	Change	-1.23%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Oct-29-25	Upgrade	Jefferies	Hold → Buy	$98
Oct-08-25	Downgrade	Oppenheimer	Outperform → Perform
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$88
Jul-29-25	Upgrade	BTIG Research	Neutral → Buy	$100
Apr-24-25	Upgrade	Piper Sandler	Neutral → Overweight	$80
Jan-30-25	Upgrade	Stifel	Hold → Buy	$75 → $90
Jan-16-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$60
Dec-16-24	Upgrade	BofA Securities	Neutral → Buy
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72
Jul-25-24	Downgrade	BofA Securities	Buy → Neutral	$105 → $75
May-30-24	Initiated	Goldman	Buy	$107
May-22-24	Upgrade	Citigroup	Neutral → Buy	$98 → $105

Show Previous Ratings

Oct-31-25 07:35PM	Closing Bell Movers: Amazon soars to all-time highs on earnings (TipRanks)
04:25PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
04:06PM	The 'Halo Effect' Bolstering Edwards Lifesciences' Biggest Moneymaker (Investor's Business Daily)
11:59AM	Edwards CFO Scott Ullem to exit post (MedTech Dive)
10:51AM	Demographic Megatrend: Stocks Poised to Benefit From Global Aging (Zacks)
10:17AM	Loading…
10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
07:56AM	Edwards boosts FY25 outlook after Q3 surpasses expectations (Medical Device Network)
Oct-30-25 11:05PM	Edwards Lifesciences Corp (EW) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:24PM	Edwards Jumps On Beat-And-Raise, Announces CFO Transition (Investor's Business Daily)
04:25PM	Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance (Investor's Business Daily)
04:15PM	Edwards Lifesciences Announces CFO Transition Plan (Business Wire)
04:13PM	Edwards Lifesciences Reports Third Quarter Results (Business Wire)
Oct-29-25 09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)
Oct-28-25 09:37AM	Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
09:15AM	Loading…
09:15AM	Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Oct-27-25 03:06PM	Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025 (Business Wire) +6.20%
02:22PM	Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025 (Business Wire)
10:00AM	Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:00AM	Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics? (Zacks)
Oct-23-25 07:53AM	Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand? (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025 (Business Wire)
Oct-21-25 06:33AM	Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results (Insider Monkey)
Oct-17-25 09:08AM	WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure? (Zacks)
08:26AM	Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings (Zacks)
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks)
Oct-10-25 08:44AM	Abbott to Report Q3 Earnings: Medical Devices Arm in Focus (Zacks)
Oct-08-25 11:16AM	TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus (Zacks)
09:45AM	Intel, FedEx downgraded: Wall Street's top analyst calls (The Fly)
Oct-07-25 09:50AM	Netflix upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
07:58AM	Loading…
Oct-06-25 07:58AM	Here's What to Expect From Edwards Lifesciences Next Earnings Report (Barchart)
Oct-02-25 07:10AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Sep-19-25 04:02PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
Sep-10-25 04:52AM	Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS) (Insider Monkey)
Sep-09-25 11:44AM	Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings (Motley Fool)
Sep-05-25 12:21PM	Edwards Lifesciences TAVR growth continues as global demand rises (Medical Device Network)
Sep-04-25 04:29PM	Top Stock Reports for Apple, Novartis & Charles Schwab (Zacks)
Sep-03-25 05:55AM	Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe (MedTech Dive)
Sep-02-25 11:13AM	Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus (Insider Monkey)
06:51AM	Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector? (Barchart)
Sep-01-25 12:20PM	3 Healthcare Pathbreakers With Long-Term Tailwinds (MarketBeat)
11:51AM	ESC 2025: Structural heart disease guidelines updated following Edwards trial results (Medical Device Network)
Aug-29-25 09:48AM	ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now? (Zacks)
09:09AM	Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care (Business Wire)
Aug-21-25 02:10PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
Aug-19-25 04:15PM	Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase (Business Wire)
Aug-15-25 05:57AM	FTC to block Edwards Lifesciences acquisition of JenaValve due to competitive concerns (Medical Device Network)
Aug-14-25 08:33AM	Abbott Taps Growing TMVR Market With Tendyne System (Zacks)
Aug-13-25 01:41PM	Edwards Lifesciences Stock: Analyst Estimates & Ratings (Barchart)
Aug-11-25 03:56PM	Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings (Motley Fool)
Aug-08-25 02:00PM	Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes (Zacks)
Aug-07-25 07:26AM	FTC files lawsuit to halt Edwards acquisition of JenaValve (Medical Device Network)
Aug-06-25 02:44PM	FTC Files Lawsuit to Block Edwards Lifesciences' Purchase of JenaValve Technology (The Wall Street Journal)
02:17PM	JenaValve Responds to FTCs Action Against Proposed Edwards Lifesciences Acquisition (GlobeNewswire)
01:41PM	FTC seeks to block Edwards Lifesciences' acquisition of JenaValve (Reuters)
01:40PM	Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve (Business Wire)
Aug-05-25 08:00AM	Court Sides with Cardiovalve in Edwards patent spat (PR Newswire)
Jul-31-25 09:52AM	10 stocks favored to gain up to 30% in a sector that has missed this year's rally (MarketWatch)
09:01AM	Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here's Why (Insider Monkey)
Jul-28-25 02:01PM	ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9% (Zacks)
Jul-25-25 04:16PM	How Boston Scientific's Loss Was Edwards Lifesciences' Gain In the Second Quarter (Investor's Business Daily) +5.54%
01:49PM	Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance (Benzinga)
01:11PM	HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View (Zacks)
10:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
09:06AM	Stock Market Today: Dow Rises After Surprise Economic Data; Tesla Climbs Amid New Robotaxi Launch (Live Coverage) (Investor's Business Daily)
08:42AM	EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down (Zacks)
03:22AM	Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... (GuruFocus.com)
Jul-24-25 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics (Zacks)
04:15PM	Edwards Lifesciences Reports Second Quarter Results (Business Wire)
05:20AM	Intel headlines busy earnings slate (MarketWatch)
04:34AM	Stock Market Today: S&P 500 eyes fresh record, Dow to dip on IBM slide, Nasdaq gain as Tesla earnings disappoint but Alphabet results sees stock gain; Intel numbers on tap. (MarketWatch)
Jul-22-25 07:43AM	Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings (Zacks)
Jul-21-25 09:15AM	Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Jul-20-25 12:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-18-25 08:44PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
08:27AM	Should You Add Edwards Lifesciences Stock to Your Portfolio Now? (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025 (Business Wire)
Jul-11-25 09:46AM	Smart Money Going in Senior Health: Key Stocks in Elderly Care (Zacks)
Jul-03-25 06:12AM	Earnings Preview: What To Expect From Edwards Lifesciences' Report (Barchart)
Jun-24-25 09:07AM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
08:55AM	NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East (PR Newswire)
08:27AM	BSX Raises 2025 Financial Outlook: What's Backing It? (Zacks)
Jun-17-25 09:37AM	ISRG's Minimally Invasive Ecosystem Powers Surgical Precision (Zacks)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
May-30-25 11:31AM	Why Is Accuray (ARAY) Up 17% Since Last Earnings Report? (Zacks)
May-28-25 10:17AM	How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott (Investor's Business Daily)
10:14AM	How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals (Investor's Business Daily)
May-23-25 11:39AM	Edwards study demonstrates value in early aortic stenosis intervention (Medical Device Network)
08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
May-22-25 09:18AM	Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick (Investing.com)
02:30AM	Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes (Business Wire)
May-20-25 08:58PM	Jim Cramer Notes Edwards Lifesciences (EW) is in a "Good Zone" (Insider Monkey)
May-19-25 08:30PM	Lightning Round: Zoom is doing a lot right, but it's taking them a really long time, says Jim Cramer (CNBC TV)
02:30PM	Trade Tracker: Bill Baruch buys Edwards Lifesciences (CNBC TV)
May-16-25 06:34AM	Should Edwards Lifesciences Stock Remain in Your Portfolio Now? (Zacks)
May-09-25 07:46AM	Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now (Insider Monkey)
May-07-25 05:24PM	Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific (Zacks)
May-06-25 07:05AM	Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
May-01-25 12:16PM	FDA approves Edwards TAVR system for asymptomatic aortic stenosis patients (Medical Device Network)
08:00AM	Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis (Business Wire)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wood Larry L	Former Affiliate	Oct 16 '25	Proposed Sale	73.02	8,950	653,522		Oct 16 04:07 PM
Chopra Daveen	CVP, TMTT	Aug 25 '25	Sale	81.95	2,500	204,865	30,996	Aug 25 06:25 PM
Chopra Daveen	Officer	Aug 25 '25	Proposed Sale	81.95	2,500	204,865		Aug 25 04:15 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Option Exercise	59.26	8,950	530,347	215,850	Aug 18 06:11 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Sale	78.06	8,950	698,679	206,900	Aug 18 06:11 PM
Wood Larry L	Officer	Aug 18 '25	Proposed Sale	78.06	8,950	698,679		Aug 18 04:29 PM
Lippis Daniel J.	CVP, JAPAC	Jul 28 '25	Sale	79.46	4,114	326,900	22,002	Jul 28 06:23 PM
Lippis Daniel J.	Officer	Jul 28 '25	Proposed Sale	79.46	4,114	326,900		Jul 28 04:04 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Option Exercise	59.26	8,950	530,347	215,850	Jun 16 05:09 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Sale	75.23	8,950	673,268	206,900	Jun 16 05:09 PM
Wood Larry L	Officer	Jun 16 '25	Proposed Sale	75.23	8,950	673,268		Jun 16 04:20 PM
Zovighian Bernard J	CEO	May 30 '25	Sale	77.21	16,099	1,243,065	9,564	Jun 03 05:15 PM
Zovighian Bernard J	CEO	Jun 03 '25	Sale	77.32	967	74,772	8,597	Jun 03 05:15 PM
Zovighian Bernard J	Officer	Jun 03 '25	Proposed Sale	77.32	967	74,772		Jun 03 04:29 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 02 '25	Sale	77.40	2,570	198,911	50,356	Jun 02 05:01 PM
BOBO DONALD E JR	Officer	Jun 02 '25	Proposed Sale	77.40	2,570	198,911		Jun 02 04:03 PM
Zovighian Bernard J	Officer	May 30 '25	Proposed Sale	77.21	16,099	1,243,064		May 30 04:31 PM
Chopra Daveen	CVP, TMTT	May 22 '25	Sale	75.08	1,500	112,612	33,496	May 22 05:08 PM
Chopra Daveen	Officer	May 22 '25	Proposed Sale	75.07	1,500	112,612		May 22 04:01 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Option Exercise	45.28	330	14,941	26,946	May 09 07:35 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Sale	74.42	330	24,560	26,616	May 09 07:35 PM
Markowitz Wayne	GM & SVP, Surgical	May 07 '25	Sale	75.08	268	20,121	9,299	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Option Exercise	45.28	11,250	509,363	52,348	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Sale	74.40	11,250	837,035	41,098	May 09 07:34 PM
Lippis Daniel J.	Officer	May 09 '25	Proposed Sale	74.42	330	24,560		May 09 04:00 PM
Markowitz Wayne	Officer	May 07 '25	Proposed Sale	75.08	268	20,121		May 07 04:48 PM
Zovighian Bernard J	CEO	May 05 '25	Option Exercise	45.28	7,462	337,855	65,746	May 06 05:13 PM
Zovighian Bernard J	CEO	May 05 '25	Sale	74.91	5,980	447,977	58,284	May 06 05:13 PM
Zovighian Bernard J	Officer	May 05 '25	Proposed Sale	74.91	5,980	447,977		May 05 04:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Option Exercise	45.28	9,500	430,129	56,706	Apr 14 06:18 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Sale	69.81	9,500	663,196	47,206	Apr 14 06:18 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Option Exercise	45.28	300	13,583	23,163	Apr 08 05:12 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Sale	70.61	300	21,183	22,863	Apr 08 05:12 PM
Lippis Daniel J.	Officer	Apr 08 '25	Proposed Sale	70.61	300	21,183		Apr 08 04:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Option Exercise	45.28	11,250	509,363	41,637	Mar 26 04:45 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Sale	70.87	11,250	797,267	30,387	Mar 26 04:45 PM
Ullem Scott B.	Officer	Mar 26 '25	Proposed Sale	70.87	22,500	1,594,534		Mar 26 04:14 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Option Exercise	45.28	9,500	430,129	56,436	Mar 13 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Sale	67.96	9,500	645,624	46,936	Mar 13 05:41 PM
Zovighian Bernard J	CEO	Mar 10 '25	Option Exercise	45.28	7,463	337,900	66,546	Mar 10 07:35 PM
Zovighian Bernard J	CEO	Mar 10 '25	Sale	69.51	6,164	428,448	59,083	Mar 10 07:35 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Option Exercise	45.28	400	18,111	22,988	Mar 10 07:34 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Sale	69.48	400	27,792	22,588	Mar 10 07:34 PM
Zovighian Bernard J	Officer	Mar 10 '25	Proposed Sale	69.51	6,164	428,448		Mar 10 04:13 PM
Lippis Daniel J.	Officer	Mar 10 '25	Proposed Sale	69.48	400	27,792		Mar 10 04:13 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Option Exercise	45.28	11,250	509,363	41,637	Feb 28 05:05 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Sale	70.78	11,250	796,327	30,387	Feb 28 05:05 PM
LORANGER STEVEN R	Director	Feb 14 '25	Option Exercise	45.32	5,739	260,073	66,111	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Sale	76.42	5,739	438,576	60,372	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Proposed Sale	76.42	5,739	438,576		Feb 14 04:11 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Option Exercise	45.28	11,250	509,363	41,811	Feb 13 06:04 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Sale	75.76	11,250	852,272	30,561	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Option Exercise	45.28	6,500	294,299	53,436	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Sale	75.75	6,500	492,363	46,936	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Option Exercise	45.28	500	22,638	23,689	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Sale	76.34	500	38,170	23,189	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Option Exercise	45.32	5,739	260,073	35,774	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Sale	75.86	5,739	435,371	30,035	Feb 13 06:04 PM
Lippis Daniel J.	Officer	Feb 13 '25	Proposed Sale	76.34	500	38,170		Feb 13 04:05 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Proposed Sale	75.86	5,739	435,371		Feb 13 04:04 PM
BOBO DONALD E JR	Officer	Feb 13 '25	Proposed Sale	75.75	25,500	1,931,579		Feb 13 04:03 PM
Lippis Daniel J.	CVP, JAPAC	Jan 16 '25	Option Exercise	45.28	500	22,638	23,689	Jan 16 05:07 PM
Lippis Daniel J.	CVP, JAPAC	Jan 16 '25	Sale	68.76	500	34,382	23,189	Jan 16 05:07 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 16 '25	Option Exercise	45.28	5,000	226,384	51,936	Jan 16 05:07 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 16 '25	Sale	68.75	5,000	343,736	46,936	Jan 16 05:07 PM
Lippis Daniel J.	Officer	Jan 16 '25	Proposed Sale	68.76	500	34,382		Jan 16 04:36 PM
Lippis Daniel J.	CVP, JAPAC	Dec 16 '24	Option Exercise	45.28	2,500	113,192	25,689	Dec 16 06:27 PM
Lippis Daniel J.	CVP, JAPAC	Dec 16 '24	Sale	74.08	2,500	185,196	23,189	Dec 16 06:27 PM
Lippis Daniel J.	Officer	Dec 16 '24	Proposed Sale	74.08	2,500	185,196		Dec 16 04:08 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Option Exercise	45.28	11,250	509,363	41,811	Dec 09 04:58 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Sale	71.68	11,250	806,406	30,561	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Option Exercise	45.28	5,000	226,384	51,936	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Sale	71.75	5,000	358,750	46,936	Dec 09 04:58 PM
Ullem Scott B.	Officer	Dec 09 '24	Proposed Sale	71.68	33,750	2,419,214		Dec 09 04:03 PM
Chopra Daveen	CVP, TMTT	Dec 06 '24	Sale	73.27	1,750	128,223	27,583	Dec 06 04:56 PM
Markowitz Wayne	GM & SVP, Surgical	Dec 06 '24	Sale	73.27	583	42,716	9,494	Dec 06 04:56 PM
Markowitz Wayne	Officer	Dec 06 '24	Proposed Sale	73.27	583	42,716		Dec 06 04:14 PM
Chopra Daveen	Officer	Dec 06 '24	Proposed Sale	73.27	1,750	128,222		Dec 06 04:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Option Exercise	45.28	5,000	226,384	51,936	Nov 13 06:16 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Sale	65.57	5,000	327,843	46,936	Nov 13 06:16 PM
BOBO DONALD E JR	Officer	Nov 13 '24	Proposed Sale	65.57	15,000	983,529		Nov 13 04:25 PM
Wood Larry L	Global President TAVR & Surg	Nov 05 '24	Sale	65.91	25,000	1,647,862	198,526	Nov 05 05:07 PM
Wood Larry L	Officer	Nov 05 '24	Proposed Sale	65.91	25,000	1,647,862		Nov 05 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience